首页> 外文期刊>International Journal of Nanotechnology >Gold nanoparticles as a sensitising agent in external beam radiotherapy and brachytherapy: a feasibility study through Monte Carlo simulation
【24h】

Gold nanoparticles as a sensitising agent in external beam radiotherapy and brachytherapy: a feasibility study through Monte Carlo simulation

机译:金纳米颗粒作为外照射和近距离放射治疗中的敏化剂:通过蒙特卡洛模拟的可行性研究

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, gold nanoparticles (GNP) have been proposed as sensitising agents in radiotherapy. Several studies, performed both through Monte Carlo simulation of dosimetric and microdosimetric enhancement in presence of GNPs and through in-vitro experiments, have clearly shown the powerfulness of such a technique in radiotherapy. Aim of the present work is to estimate the dose enhancement during external beam radiotherapy and brachytherapy in tissues loaded with different GNP concentrations. We developed two Monte Carlo simulations in GEANT4: one reproducing a medical Linac operating at 6 MV, irradiating a volume of soft tissue containing GNP-doped sub-volumes at various depths; the second one representing an ~(192)Ir source irradiating a cylindrical cavity, in presence of a shallow volume distribution of GNPs. The Linac simulation yielded relative percent dose increases ranging from 1.6% for GNP concentrations of 1% in weight to 18% for 10% GNP concentrations, while the high-energy brachytherapy ~(192)Ir source gave 6% of relative dose increase at 1% of concentration up to more than 70% increase at 10% of GNP concentration. Such dose enhancements are mainly due to the increased photoelectron and characteristic X-ray production from the GNPs and, at a lower percentage, to the Auger electrons escaping from the GNPs. These scarcely penetrating radiations induce relevant microdosimetric intensifications in the surrounding of each GNP, leading to a biological damage at cellular and sub-cellular level, which depends on the biological distribution of GNPs within the target cells.
机译:近年来,金纳米颗粒(GNP)已被提出作为放射治疗中的敏化剂。通过在存在GNPs时进行剂量学和微剂量学增强的蒙特卡罗模拟以及通过体外实验进行的几项研究清楚地表明了这种技术在放射治疗中的强大功能。本工作的目的是估计在外部射线放疗和近距离放射治疗期间,在不同GNP浓度的组织中的剂量增加。我们在GEANT4中开发了两个蒙特卡洛模拟:一个模拟以6 MV运行的医用直线加速器,在一定深度照射一定体积的含有GNP掺杂子体积的软组织。第二个代表的是〜(192)Ir源,在GNP的体积分布较浅的情况下,它照射圆柱形腔。 Linac模拟产生相对百分比剂量增加,范围从重量百分比为1%的GNP浓度的1.6%到GNP浓度为10%的18%,而高能近距离放射疗法〜(192)Ir来源在1时相对剂量增​​加了6%。 GNP浓度的10%时,浓度的百分比增加到70%以上。这样的剂量增加主要是由于来自GNP的光电子和特征性X射线产量增加,以及归因于从GNP逸出的俄歇电子的百分比较低。这些几乎没有穿透的辐射会在每个GNP的周围引起相关的微剂量增强,从而导致细胞和亚细胞水平的生物损伤,这取决于目标细胞内GNP的生物学分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号